TUCSON, Ariz., Dec. 8, 2020 /PRNewswire/ -- Procyon Technologies LLC today announced that it has entered into an exclusive research collaboration and license agreement with Novo Nordisk A/S to develop ...

Tampa, Fla. (Jan. 21, 2009) – Early attempts at islet cell transplantation to treat diabetes date to the nineteenth century, decades before the discovery of insulin in the 1930s. In recent years, ...

A collaboration between researchers from Cornell and University of Alberta, Edmonton, has created a new technique to treat type 1 diabetes: implanting a device inside a pocket under the skin that can ...

Scientists have developed a new implantable device that has the potential to change the way Type 1 diabetics receive insulin. The thread-like implant, or SHEATH (Subcutaneous Host-Enabled Alginate ...

CHICAGO — Ten people with type 1 diabetes, who had recurrent severe hypoglycemia and hypoglycemic unawareness, have remained insulin-independent for over a year following allogeneic stem cell-derived ...

The need to avoid immunosuppression is often the driving force behind research into alternative therapeutic options for the treatment of a range of diseases. One such disease is type I diabetes, which ...

JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D ...

SAN DIEGO, April 17, 2018 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, today announced the recent issuance of more than 200 patents, which provide protection to the ...

ITHACA, N.Y. - For the more than 1 million Americans who live with type 1 diabetes, daily insulin injections are literally a matter of life and death. And while there is no cure, a Cornell ...